Terms: = Prostate cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Diagnosis
35 results:
1. Influence of Humoral Response Against GnRH, Generated by Immunization with a Therapeutic Vaccine Candidate on the Evolution of Patients with Castration-Sensitive prostate Adenocarcinoma.
Campal-Espinosa AC; Junco-Barranco JA; Fuentes-Aguilar F; Calzada-Aguilera L; Rivacoba-Betancourt A; Rodríguez-Bueno RH; Bover-Campal AC; Bover-Fuentes EE; González L; de Quesada L; Alvarez A; Garay-Pérez HE
Technol Cancer Res Treat; 2023; 22():15330338231207318. PubMed ID: 37828833
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Sarcopenia Onset Prior to cancer diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
3. A Nationwide Study of Differences in Surgical Treatment Rates and Oncological Outcomes for prostate cancer according to Economic Status and Region.
Yoo S; Oh S; Cho MC; Son H; Jeong H
Cancer Res Treat; 2023 Apr; 55(2):652-658. PubMed ID: 36510653
[TBL] [Abstract] [Full Text] [Related]
4. Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer.
Kurokawa R; Kato S; Koyama H; Ishida M; Kurokawa M; Kuroda R; Ushiku T; Kume H; Abe O
Eur J Radiol; 2022 Dec; 157():110595. PubMed ID: 36356462
[TBL] [Abstract] [Full Text] [Related]
5. Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive prostate cancer.
Freeman MN; Jang A; Zhu J; Sanati F; Nandagopal L; Ravindranathan D; Desai A; Phone A; Nussenzveig R; Jaeger E; Caputo SA; Koshkin VS; Swami U; Basu A; Bilen MA; Agarwal N; Sartor O; Burgess EF; Barata PC
Oncologist; 2022 Mar; 27(3):220-227. PubMed ID: 35274720
[TBL] [Abstract] [Full Text] [Related]
6. Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients?
Levin BA; Lama DJ; Sussman J; Guan T; Rao M; Tobler J; Verma S; Sidana A
Aging Male; 2022 Dec; 25(1):23-28. PubMed ID: 34983290
[TBL] [Abstract] [Full Text] [Related]
7. Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions.
Al Hussein Al Awamlh B; Marks LS; Sonn GA; Natarajan S; Fan RE; Gross MD; Mauer E; Banerjee S; Hectors S; Carlsson S; Margolis DJ; Hu JC
Urol Oncol; 2020 Jul; 38(7):637.e9-637.e15. PubMed ID: 32307327
[TBL] [Abstract] [Full Text] [Related]
8. Postdiagnosis Body Mass Index, Weight Change, and Mortality From prostate cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic prostate cancer.
Troeschel AN; Hartman TJ; Jacobs EJ; Stevens VL; Gansler T; Flanders WD; McCullough LE; Wang Y
J Clin Oncol; 2020 Jun; 38(18):2018-2027. PubMed ID: 32250715
[TBL] [Abstract] [Full Text] [Related]
9. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract] [Full Text] [Related]
10. Comparisons between magnetic resonance/ultrasound fusion-guided biopsy and standard biopsy in the diagnosis of prostate cancer: A prospective cohort study.
Zhu G; Wang Q
Medicine (Baltimore); 2018 Sep; 97(36):e11962. PubMed ID: 30200076
[TBL] [Abstract] [Full Text] [Related]
11. Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.
Białkowska K; Marciniak W; Muszyńska M; Baszuk P; Gupta S; Jaworska-Bieniek K; Sukiennicki G; Durda K; Gromowski T; Prajzendanc K; Cybulski C; Huzarski T; Gronwald J; Dębniak T; Scott RJ; Lubiński J; Jakubowska A
PLoS One; 2018; 13(7):e0201065. PubMed ID: 30036379
[TBL] [Abstract] [Full Text] [Related]
12. Oncologic emergencies in a cancer center emergency department and in general emergency departments countywide and nationwide.
Yang Z; Yang R; Kwak MJ; Qdaisat A; Lin J; Begley CE; Reyes-Gibby CC; Yeung SJ
PLoS One; 2018; 13(2):e0191658. PubMed ID: 29462166
[TBL] [Abstract] [Full Text] [Related]
13. Incidence and relative risk for developing cancer among patients with COPD: a nationwide cohort study in Taiwan.
Ho CH; Chen YC; Wang JJ; Liao KM
BMJ Open; 2017 Mar; 7(3):e013195. PubMed ID: 28279996
[TBL] [Abstract] [Full Text] [Related]
14. Serum BSP, PSADT, and Spondin-2 levels in prostate cancer and the diagnostic significance of their ROC curves in bone metastasis.
Zhu BP; Guo ZQ; Lin L; Liu Q
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):61-67. PubMed ID: 28121355
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic significance of bone marrow metastases: evaluation of 58 cases.
Kucukzeybek BB; Calli AO; Kucukzeybek Y; Bener S; Dere Y; Dirican A; Payzin KB; Ozdemirkiran F; Tarhan MO
Indian J Pathol Microbiol; 2014; 57(3):396-9. PubMed ID: 25118730
[TBL] [Abstract] [Full Text] [Related]
16. A study on distribution of cancer cases diagnosed in Çorum.
Baş Y; Uzbay P; Güney G; Erenler BH; Yilmaz D; Ozdemır C
Turk Patoloji Derg; 2014; 30(2):118-23. PubMed ID: 24782299
[TBL] [Abstract] [Full Text] [Related]
17. cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; Visser O; Brenner H; Ardanaz E; Bielska-Lasota M; Engholm G; Nennecke A; Siesling S; Berrino F; Capocaccia R;
Lancet Oncol; 2014 Jan; 15(1):23-34. PubMed ID: 24314615
[TBL] [Abstract] [Full Text] [Related]
18. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
Bauer SR; Richman EL; Sosa E; Weinberg V; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2013 Dec; 73(16):1786-95. PubMed ID: 24038157
[TBL] [Abstract] [Full Text] [Related]
19. Educational inequalities in cancer survival: a role for comorbidities and health behaviours?
Aarts MJ; Kamphuis CB; Louwman MJ; Coebergh JW; Mackenbach JP; van Lenthe FJ
J Epidemiol Community Health; 2013 Apr; 67(4):365-73. PubMed ID: 23225743
[TBL] [Abstract] [Full Text] [Related]
20. Chlamydia pneumoniae infection and risk for lung cancer.
Chaturvedi AK; Gaydos CA; Agreda P; Holden JP; Chatterjee N; Goedert JJ; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1498-505. PubMed ID: 20501758
[TBL] [Abstract] [Full Text] [Related]
[Next]
